This document summarizes a commentary that argues for rethinking mental illness as disorders of the brain rather than of the mind. Recent advances in genetics and neuroscience are transforming understanding of psychiatric disorders. Insights from these fields show that mental illnesses are likely caused by developmental processes shaped by complex interactions between genetics and environment. However, current diagnostic categories do not align well with findings from these sciences. The authors argue that reconceptualizing mental disorders as disorders of the brain could lead to early detection and preventive or preemptive interventions.
1. Site designed and operated by: got2bedigital.com
Back to DSM / Psychiatry
Rethinking Mental Illness
Thomas R. Insel, MD
Philip S. Wang, MD, DrPH
THE FIRST 2010 ISSUE OF NATURE, THE EDITOR, PHILIP
Campbell,1 suggested that the next 10-year period is likely to be
the "decade for psychiatric disorders." This was not a prediction
of an epidemic, although mental illnesses are highly prevalent,
nor a suggestion that new ill- nesses would emerge. The key
point was that research on mental illness was, at long last,
reaching an inflection point at which insights gained from
genetics and neuroscience would transform the understanding of
psychiatric ill- nesses. The insights are indeed coming fast and
furious. In this Commentary, we suggest ways in which
genomics and neuroscience can help reconceptualize disorders
of the mind as disorders of the brain and thereby transform the
2. practice of psychiatry.
Compelling reasons to look for genes that confer risk for mental
illness come from twin studies demonstrating high heritability for
autism, schizophrenia, and bipolar disorder.2 Although there
have been notable findings from linkage and genome-wide
association studies, with candidate genes and specific alleles
identified for each of the major mental disorders, those that have
been replicated explain only a fraction of the heritability.
Where is the missing genetic signal for mental illness? The
discovery that large (??1 megabase) structural or copy number
variants, such as deletions and duplications, are 10- fold more
common in autism and schizophrenia is an important clue.3,4
Copy number variants are individually rare, sometimes restricted
to a single family or developing de novo in an individual.
Although "private mutations" are rare
(reminiscent of Tolstoy's dictum that "each unhappy family is
unhappy in its own way"), they are in aggregate remarkably
common, spread across vast expanses of the genome, and
ultimately could explain more genetic risk than common variants.
Although many of the genes implicated are involved in brain
development, copy number variants do not appear to be specific
for illnesses in the current diagnostic scheme. Within families,
the same copy number variant may be associated with
schizophrenia in one person, bipolar disorder in another, and
attention-deficit/hyperactivity disorder in yet another. The
genetics of mental illness may really be the genetics of brain
development, with different out-
1970 JAMA, May 19, 2010-Vol 303, No. 19 (Reprinted)
comes possible, depending on the biological and environmental
context.
The same twin studies that point to high heritability also
demonstrate the limits of genetics: environmental factors must
be important for mental disorders. The advent of epigenomics,
which can detect the molecular effects of experience, may
provide a powerful approach for understanding the critical effects
of early-life
events and environment on adult patterns of behavior.
3. Epigenomics can now map changes across the entire genome
with unbiased, high- throughput technologies and point to the
mechanisms by which experience confers enduring changes in
gene expression and, ultimately, changes in brain activity and
function. Epigenomic modifications that alter transcription may
also be a mechanism for mental illness, even in the absence of
common or rare structural variants. For instance, a rare copy
number variant detected in autism deletes the oxytocin receptor
gene. In many individuals with autism who do not have this
deletion, epigenomic modifications appear to silence this gene.5
Genomics and epigenomics already point to diverse molecular
pathways that confer risk of mental illness. What binds these
diverse molecular mechanisms together to yield clusters of
symptoms recognized as the syndromes of psychiatric
disorders? Increasingly, clinical neuroscientists are identifying
specific circuits for major aspects of illness. But just as the
genetic variants do not map selectively onto current diagnostic
categories, so, also, circuits seem to be associated with
cognitive and behavioral functions, without a one- to-one
correspondence to diagnosis. For instance, the neural basis of
extinction learning, which was first mapped in the rat brain,
appears to be conserved in the human brain, with key nodes
including ventromedial prefrontal cortex, amygdala, and
hippocampus.6 Rather than defining the biology of a single
illness, extinction is an important feature of posttraumatic stress
disorder, obsessive-compulsive disorder, and various phobias.
Two noteworthy points are emerging from systems
neuroscience. First, there seem to be emerging relationships
between genetic variation and development of neural circuits that
mediate complex cognition and behavior, from re- ward to
emotion regulation. Second, the current diagnosistic categories,
based on clinical characteristics, do not seem to align well with
findings from genetics and neuroscience. The National Institute
of Mental Health recently launched the Research Domain
Criteria project to reformulate psychiatric diagnosis according, in
part, to emerging biology rather than the current approach, which
is limited to clinical consensus.7
4. Reconceptualizing disorders of the mind as disorders of the brain
has important implications for how and when to intervene. From
the study of neurodegenerative disorders such as Parkinson
disease, Huntington disease, and Alzheimer disease, it is known
that behavioral and cognitive symptoms are late events,
occurring years after initial signs of neuronal damage. Although
mental illnesses are more likely neurodevelopmental rather than
neurodegenerative disorders, the behavioral and cognitive
manifestations that signify these as "mental" illnesses may be
late stages of processes that start early in development. In
medicine, the best outcomes are rarely observed from
treatments initiated in late phases of an illness. If genetics and
neuroscience could provide rigorous, specific, early detection
years before
psychosis or depression, these illnesses might be redefined in
terms of a trajectory. As a result, interventions, rather than being
ameliorative or rehabilitative, could become preemptive or even
preventive. But this transformation in diagnosis and treatment,
which can be informed by recent progress in cardiovascular
disease and cancer, will depend on an intense focus on the
genetics and circuitry underlying mental illness to ensure new
approaches to detecting risk, validating diagnosis, and
developing novel interventions that may be based on altering
plasticity or retuning circuitry rather than neurotransmitter
pharmacology.
Recent examples illustrate how these genetic and basic
neuroscience discoveries can rapidly lead to new clinical
innovations that will make such a transformation in practice
possible. For example, elucidation of the roles that genetic and
downstream effects on protein synthesis play in the
pathogenesis of fragile X syndrome8-an important cause of
autism and inherited mental retardation-has quickly opened the
door to clinical trials of pharmacologic treatments for that
disorder's debilitating cognitive impairments. Likewise, advances
in understanding the circuitry underlying extinction learning have
led to promising new behavioral approaches for blocking
previously learned fear responses.9 Even as new interventions
5. are developed for anxiety disorders, recent discovery of genetic
variants associated with efficacy of existing behavioral
treatments suggests new ways to tailor their use.10 Such
examples provide strong bases for hope that insights emerging
from genetics and neuroscience will be translated into rational
development of new robust and personalized treatments.
A "decade for psychiatric disorders" cannot come too soon.1
With no validated biomarkers and too little in the way of novel
medical treatments since 1980, families need science to provide
more than hope. Genetics and neuroscience finally have the
tools to transform the diagnosis and treatment of mental illness.
But first, it is time to rethink mental disorders, recognizing that
these are disorders of brain circuits likely caused by
developmental processes shaped by a complex interplay of
genetics and experience.
Financial Disclosures: None reported.
REFERENCES
1. Campbell P. A decade for psychiatric disorders. Nature.
2010;463(7277):9.
2. Insel TR. Disruptive insights in psychiatry: transforming a
clinical discipline. J Clin Invest. 2009;119(4):700-705.
3.
SebatJ,LakshmiB,MalhotraD,etal.Strongassociationofdenovocop
ynum- ber mutations with autism. Science. 2007;316(5823):445-
449.
4.
WalshT,McClellanJM,McCarthySE,etal.Rarestructuralvariantsdis
ruptmul- tiple genes in neurodevelopmental pathways in
schizophrenia. Science. 2008; 320(5875):539-543.
5. Gregory SG, Connelly JJ, Towers AJ, et al. Genomic and
epigenetic evidence for oxytocin receptor deficiency in autism.
BMC Med. 2009;7:62.
6.
DelgadoMR,NearingKI,LedouxJE,PhelpsEA.Neuralcircuitryunder
lyingthe regulation of conditioned fear and its relation to
extinction. Neuron. 2008; 59(5):829-838.
7. This commentary will surely prove to be an historical event, in as
much as it has been written by two psychiatrists.
The fact is however that the connection between mental illness
and complex cognitive and behavioral disabilities was made as
long ago as 1996.
Following the description of Fetal Alcohol Syndrome in the
Lancet, 1973 a long term study was initiated by Streissguth
et.al. The study showed
that 95% of those diagnosed FAS/FAE [FASD] would
subsequently receive diagnoses from the DSM, often multiple.
In my experience it is not uncommon for the number of
diagnoses to be four, or more on occasions.
The striking connection between FASD and mental health has
largely been ignored by the psychiatric community.
A personal review of the American Journal of Psychiatry,
January 1996 to September 2007, found only one title referring
to FASD, representing
approximately 0.08 per cent of all articles published in that time.
A similar review of the Canadian Journal of Psychiatry, February
1996, to
October 2007, also found only one title referring to FASD,
representing approximately 0.03 per cent of all articles published
in that time.
Others have demonstrated the lack of interest and knowledge of
FASD by the psychiatric community.
With the rapid development of epigenetics it is now apparent that
alcohol is a major cause of changes of gene expression. It plays
its role at
preconception, preimplantation and gastrulation, as it does
through out the pregnancy.
The epigenetic effect of alcohol applies to males and females
and may be passed on to future generations.
As the commentary states, many environmental factors
contribute to changes in gene expression e.g. famine, abuse and
8. neglect.
When we combine the direct impact of alcohol on genes with its
wider cause of domestic violence and neglect for example, the
true contribution
of alcohol to mental illness can be clearly seen.
As the authors of the Commentary state -
"But first, it is time to rethink mental disorders, recognizing that
these are disorders of brain circuits likely caused by
developmental processes
shaped by a complex interplay of genetics and experience."
The first step to rethinking mental illness is to understand FASD.
Surely the day will come when the genes that control individual
aspects of brain function will be identified. Changes in gene
expression will be
related to clinical presentations, such as those in the DSM.The
generation at which the changes in gene expression occurred
will be
determined.The agent that caused the change [with other
environmental factors, in some cases] will be identified.Then we
will understand to what
degree alcohol has determined the nature of mental illness.
B. Stanley, M.B.Ch.B., F.R.C.S. [C ]
REFERENCES
1-The Stream of Consciousness. William James. Psychology,
Chapter XI 1892.
2-W.C. Sullivan, Stewart Scholar. A Note on the Influence of
Maternal
Inebriety on the Offspring. Journal of Mental Science. 1899.
3-Stockard CR: The effect on the offspring of intoxicating the
male parent and
the transmission of the defects to subsequent generations.
Am Nat 1913, 47:641-682. 5.
4-Pattern Of Malformations in Offspring Of Chronic Alcoholic
9. Mothers, Jones
et.al. The Lancet: Saturday 9 June 1973.
5-The Effects of Drinking on Offspring; An Historical Survey of
American
British Literature. Rebecca Warner, Henry L. Rosett. The Journal
of Alcohol
Studies. 1975.
6-The fetal alcohol syndrome in mice: maternal variables.
Chernoff Teratology
1980, 22:71-75. 20.!
7-Decreased birth weight in infants of alcoholic women who
abstained during
pregnancy. Little RE, Streissguth AP, Barr HM, Herman CS: J
Pediatr 1980,
96:974-977.
8-Paternal effects of ethanol in the Long-Evans rat. Mankes RF,
LeFevre R,
Benitz KF, Rosenblum I, Bates H, Walker Al, Abraham R,
Rockwood W:
Jtoxicol Environ Health 1982, 10:871-878.
9-Learning achievement in sons of alcoholics. Hegedus AM,
Alterman AI, Tarter
RE: Alcohol Clin Exp Res 1984, 8:330-333.61.
10-Fetal alcohol effects in long and short-sleep mice: activity,
passive avoidance,
and in utero ethanol levels. Gilliam DM, Stilman A, Dudek BC,
Riley EP:
Neurotoxicol Teratol 1987, 9:349-357.21.
11-Father's drinking and infant birth weight: report of an
association. Little RE,
Sing CF: Teratology 1987, 36:59-65.60.
12-Two generations of maternal alcohol consumption in mice:
effect on
pregnancy outcome. Becker HC, Randall CL: Alcohol Clin Exp
Res 1987, 11-
240-242.
13-Maternal genetic effects on ethanol teratogenesis and
10. dominance of relative
embryonic resistance to malformations. Gilliam DM, Irtenkauf
KT:: Alcohol
Clin Exp Res 1990, 14:539-545.
14-Ethanol consumption inhibits fetal DNA methylation in mice:
Implications
for the fetal alcohol syndrome. Garro AJ, McBeth DL, Lima V,
Lieber CS:
Alcohol Clin Exp Res 1991,15:395-398.
15-Underestanding the Occurrence of Secondary Disabilities in
Clients with
Fetal Alcohol Syndrome [FAS] and Fetal Alcohol Effects [FAE].
Final Report,
Augutst 1996, Streissguth et.al., Fetal Alcohol and Drug Unit,
University of
Washington, Seattle, U.S.A.
16-Incidence of fetal alcohol syndrome and prevalence of
alcohol-related
neurodevelopmental disorder. Sampson PD, Streissguth AP,
Bookstein FL,
Little RE, Clarren SK, Dehaene P, Hanson JW, Graham JM Jr:
Teratology
1997, 56:317-326.
17-Association of prenatal alcohol exposure with behavioral and
learning
problems in early adolescence. Olson HC, Streissguth AP,
Sampson PD, Barr
HM, Bookstein FL, Thiede K: J Am Acad Child Adolesc
Psychiatry 1997,
36:1187-1194.
18-Mental Illness in Adults With Fetal Alcohol Syndrome or Fetal
Alcohol
Effects. Chris Famy et.al., Am. J. Psychiatry 1998, 155:552-554.
19-Comparison of Social Abilities of Children with FAS to those
Children with
Similar IQ Scores and Normal Controls. Alcoholism; Thomas
et.al. Clinical and
11. Experimental Research, 22[2]. 1998.
20-Comorbidity Between Abuse of and Adult and DSM-III-R
Mental Disorders:
Evidence From and Epidemiological Study, Kirstie K. Danielson,
Terrie E.
Moffitt, PH.D., Avshalom Caspi, Ph.D., and Phil A. Silva, Ph.D.
Am J Psychiatry
1998, 155:131-133.
21-Epigenetic reprogramming in mammalian development.
Science ReikW,
Dean W, Walter 2001, 293:1089-1093.
22-Teratogenic Effects of Alcohol on Brain and Behavior. Sarah
N. Mattson
et.al. Alcohol Research and Health. Vol 25 No 3, 2001.
23-Comparison of the Adaptive Functioning of Children
Prenatally Exposed to
Alcohol to a Nonexposed Cllinical Sample. Whaley et.al. 25[7],
July 2001.
24-Prenatal alcohol exposure and childhood behavior at age 6 to
7 years: 1 dose
response effect, B.Sood et.al., Pediatrics, 2001 Aug, 108[2];
E34.
25-Clinical Implications of a Link Between Fetal Alcohol
Spectrum Disorder and
Attention Deficit Hyperactivity Disorder. Kieran D O'Mally, Jo
Nanson, Can. J
Psychiatry, Vol.47, No4, May 2002.
26-the Integration of Neurology, Psychiatry, Joseph B. Martin,
M.D.,
Ph.D.Neuroscience in the 21st Century (Am J Psychiatry 2002,
159:695-704).
27-Paternal alcohol exposure affects sperm cytosine
methyltransferase
messenger RNA levels. Bielawski DM, Zaher FM, Svinarich DM,
Abel EL:
Alcohol Clin Exp Res 2002, 26:347-351.
28-Youth with Comorbid Disorders, Kieran D. O'Mally, The
12. Handbook of Child
and Adolescent Systems of Care, Chapter Thirteen, 2003.
29-Fetal Alcohol Spectrum Disorder [FASD]: A Need for Closer
Examination by
the Criminal Justice System. Timothy E. Moore, Melvyn Green.
Criminal
Reports, Vol 19 Part 1, July 2004.
30-Fetal Alcohol Spectrum Disorder [FASD], Public Health
Agency of Canada,
Cat.No. H124-4/2004, ISBN 0-662-68619-5, Publication No.
4200.
31-Report on Prenatal Exposure to Alcohol. Professor Peter
Hepper, Belfast, N.
Ireland, 1998.
32-Maternal alcohol consumption during pregnancy may delay
the development
of spontaneous fetal startle behavior. Peter G. Hepper et.al.,
Physiology and
Behavior, 83[2005], 711-714.
33-Fetal alcohol Spectrum Disorders: an Overview with
Emphasis on Changes in
Brain and Behavior, Edward P. Riley and Christie L. McGee,
department of
Psychology and the Center for Behavioral Teratology, San Diego
State
University, San Diego, 2005.
34-Binge Drinking during Pregnancy as a Predictor of Psychiatric
Disorders on
the Structured Clinical Interview for DSM-IV in Young Adult
Offspring., Helen
M. Barr et.al., American Journal of Psychiatry, 2006: 161:1061-
1065.
35-Metabolic and genetic factors contributing to alcohol induced
effects and fetal
alcohol syndrome. Gemma S. Vichi S, Testai E: Neurosci
Biobehav Re 2007,
31:221-229.
13. 36-Through the Lens of a Child Psychiatrist: the Need to
Distinguish FASD
from other Neurodevelopmental Disorders in the DSM-V, Susan
D. krich, MD,
MPH Iceberg June 2008.
37-Fetal Alcohol Spectrum Disorders: the epigenetic
Perspective. Phillip C
Haycock, Bor Papers in Press. Published May 27, 2009. The
Society for the
Study of Reproduction.
38-Ethanol teratogenesis in five inbred strains of mice. Downing
C, Balderrama-
Durbin C, Broncucia H, Gilliam D, Johnson Alcohol Clin Exp Res,
2009,
33:1238-1245. 19.!
39-Fetal alcohol spectrum disorders and alterations in brain and
behaviour.
Guerri C, Bazinet A, Riley EP: Alcohol Alcohol 2009, 44:108-114.
40-Alcohol exposure alters DNA methylation profiles in mouse
embryos at early
neurulation. Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou
FC: epigenetics.
2009, 4:500-511.
41-Effect of alcohol consumption on CpG methylation in the
differentially
methylated regions of H19 and IG-DMR in male gametes:
Implications for fetal
alcohol spectrum disorders, Ouko LA, Shantikumar K, Knezovich
J, Haycock P,
Schnugh DJ, Ramsay M: Alcohol Clin Exp Res 2009, 33:1615-
1627.
42-Aspects of Tetal Learning and Memory, Dirix, CEH, and Nij
(Maastricht
University Medical Centre), Jongsma, HW (University Medical
Centre St.
Radboud), and Hornstra, G (Ma University Medical Centre).
Child
14. Development, Vol. 80, Issue 4, 2009.
43-Genetics and epigenetic insights into fetal alcohol spectrum
disorders,
Michele Ramsay, Genome Medicine, 2010, 2.27.
44-NIAAA Home > Publications Teratogenic Effects of Alcohol
on Brain and
Behavior, Sarah N. Mattson Ph.D., Amy M. Schoenfeld and
Edward P. Riley,
Ph.D. University San Diego.
45-NIAAA Home > Publications Effects of Prenatal Alcohol
Exposure on
Executive Functioning Plyadasa W. Kodituwakku, Ph.D, Wendy
Kalberg, MA,
Phillip A. May, Ph.D.
46-Roy Eyal, MD, American Academy of Child & Adolescent
Psychiatry
AACAP) 56th Annual Meeting.
Written in response to "Rethinking Mental Illness " declined for
publication
B.Stanley